News

Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.
I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...
Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.
UNH stock soared after Warren Buffett’s Berkshire Hathaway revealed it bought shares of the healthcare company. Nonetheless, ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
The blue-chip Dow Jones ended higher after hitting an intraday record high on Friday, as UnitedHealth's shares jumped after ...
Shares of UnitedHealth Group surged nearly 14% on Friday after billionaire Warren Buffett's Berkshire Hathaway bought 5 ...
Stocks were mostly higher Monday as President Donald Trump was scheduled to meet with Ukraine President Volodymyr Zelensky ...
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...